PATH applauds release of US funding for Gavi, the Vaccine Alliance
The renewed investment will help protect millions of children through lifesaving immunization.
PATH applauds the US government’s decision to release fiscal year 2025 and fiscal year 2026 funding for Gavi, the Vaccine Alliance, reaffirming the United States’ longstanding commitment to protecting children and communities from vaccine-preventable diseases around the world.
Since its founding in early 2000, Gavi has vaccinated over 1.2 billion children against 20 diseases and has prevented an estimated 20.6 million deaths. The renewal of US funding will help Gavi and its partners continue expanding access to lifesaving vaccines and strengthening routine immunization systems. At a time when countries around the world face mounting health challenges, sustained investment in immunization remains one of the most effective ways to save lives and build healthier, more resilient communities.
“Immunization is one of the most effective and equitable investments in global health,” said Deborah Atherly, Global Head of Policy, Access, and Introduction at PATH’s Center for Vaccine Innovation and Access (CVIA). “These funds will help countries sustain essential vaccination programs and protect millions of children from preventable diseases. Maintaining that momentum is critical to preserving decades of progress.”
Over the past year, PATH worked alongside partners to engage bipartisan members of Congress and congressional staff in support of sustained US investment in Gavi and global immunizations. By providing technical expertise, developing policy resources, and engaging directly with congressional offices, PATH helped inform policymakers about Gavi’s lifesaving impact and the critical role of continued US leadership in global health.
“Congressional champions and coalition partners ... kept the focus on what matters—immunization access.”— Bernard Aryeetey, Senior Director, Policy, Advocacy, and Influence
“This welcome news reflects sustained advocacy by congressional champions and coalition partners who kept the focus on what matters—immunization access for communities worldwide,” said Bernard Aryeetey, Senior Director of Policy, Advocacy, and Influence at PATH. “We’re grateful to our partners, glad to contribute, and encouraged that the United States has reaffirmed its commitment to global immunization.”
With continued support, Gavi will keep expanding access to vaccines for children and families around the world.